- CA$7.08m
- CA$7.07m
- 36
- 44
- 12
- 22
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | -37.3 | 5.25 | 1.38 | 5.03 | -29.1 |
Operating Profit | 37.3 | -5.25 | -1.38 | -5.03 | 29.1 |
Net Income Before Taxes | 37.3 | -5.25 | -1.38 | -5.03 | 29.1 |
Net Income After Taxes | 37.3 | -5.25 | -1.38 | -5.03 | 29.1 |
Net Income Before Extraordinary Items | |||||
Net Income | 37.3 | -5.25 | -1.38 | -5.03 | 29.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 37.3 | -5.25 | -1.38 | -5.03 | 29.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.037 | -0.027 | -0.007 | -0.023 | 0.108 |